A Fatal Complication Caused by Occult Pheochromocytoma After Splenic Artery Embolization for Malignant Hypersplenism

por Dinkelaar, Wouter, Elgersma, Otto, Levin, Mark-David
Publicado 2011

Disseminated cryptococcal disease during treatment with idelalisib and corticosteroids for follicular lymphoma

por Hengeveld, Paul J, de Jongh, Eva, Westerweel, Peter E, Levin, Mark-David
Publicado 2020

New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia

por Westerweel, Peter E., te Boekhorst, Peter A. W., Levin, Mark-David, Cornelissen, Jan J.
Publicado 2019

Abdominal pain in combination with an unexplained hemolytic anemia are crucial signs to test for paroxysmal nocturnal hemoglobinuria: A case report

por Elias, N.S., Riedl, Jürgen, Stouten, Karlijn, Levin, Mark‐David, Wolfhagen, Frank, Eefting, Mathijs, Vermeer, Henricus Jan
Publicado 2018

Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features

por van der Straten, Lina, Hengeveld, Paul J., Kater, Arnon P., Langerak, Anton W., Levin, Mark-David
Publicado 2021

Diagnostics in anaemia of chronic disease in general practice: a real-world retrospective cohort study

por Schop, Annemarie, Stouten, Karlijn, van Houten, Ron, Riedl, Jürgen, van Rosmalen, Joost, Bindels, Patrick JE, Levin, Mark-David
Publicado 2018

Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice

por Kockerols, Camille C.B., Valk, Peter J.M., Levin, Mark-David, Pallisgaard, Niels, Cornelissen, Jan J., Westerweel, Peter E.
Publicado 2020

Long-term outcomes in patients newly diagnosed with iron deficiency anaemia in general practice: a retrospective cohort study

por Schop, Annemarie, Stouten, Karlijn, Riedl, Jurgen, van Houten, Ron, van Rosmalen, Joost, Wolfhagen, Frank, Bindels, Patrick J E, Levin, Mark-David
Publicado 2019

Preventing overuse of laboratory diagnostics: a case study into diagnosing anaemia in Dutch general practice

por Kip, Michelle M. A., Oonk, Martijn L. J., Levin, Mark-David, Schop, Annemarie, Bindels, Patrick J. E., Kusters, Ron, Koffijberg, Hendrik
Publicado 2020

Protocol description of the HOVON 141/VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/...

por Levin, Mark-David, Kater, Arnon P, Mattsson, Mattias, Kersting, Sabina, Ranti, Juha, Thi Tuyet Tran, Hoa, Nasserinejad, Kazem, Niemann, Carsten Utoft
Publicado 2020

Occurrence of Hospital-Associated Thrombosis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study

por Visser, Chantal, Kruip, Marieke J. H. A., Brantsma-Van der Graaf, Janet, van Thiel, Eric E., Levin, Mark-David, Westerweel, Peter E.
Publicado 2023

Conditional relative survival among patients with chronic lymphocytic leukaemia: A population‐based study in the Netherlands

por van der Straten, Lina, Levin, Mark‐David, Visser, Otto, Posthuma, Eduardus F.M., Doorduijn, Jeanette K., Kater, Arnon P., Dinmohamed, Avinash G.
Publicado 2021

Prevalence of potential underlying aetiology of macrocytic anaemia in Dutch general practice

por Stouten, Karlijn, Riedl, Jurgen A., Droogendijk, Jolanda, Castel, Rob, van Rosmalen, Joost, van Houten, Ron J., Berendes, Paul, Sonneveld, Pieter, Levin, Mark-David
Publicado 2016

S140: IBRUTINIB SENSITIZES CLL CELLS TO VENETOCLAX BY INTERRUPTING TLR9-INDUCED CD40 UPREGULATION AND PROTEIN TRANSLATION

por Kielbassa, Karoline, Haselager, Marco, Bax, Danique, van Driel, Bianca, Levin, Mark-David, Kersting, Sabina, Svanberg, Rebecka, Niemann, Carsten U., Kater, Arnon P., Eldering, Eric
Publicado 2023

P620: GENETIC ALTERATIONS AND OUTCOMES WITH FIXED-DURATION IBRUTINIB+VENETOCLAX (IBR+VEN): RESULTS FROM THE PHASE 3 GLOW STUDY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL

por Kater, Arnon, Hodkinson, Brandon, Moreno, Carol, Munir, Talha, Levin, Mark-David, Niemann, Carsten, Qi, Keqin, Sinet, Pierre, Baeten, Kurt, Bennett Caces, Donne, Srinivasan, Srimathi
Publicado 2023

Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study

por van Oers, Marinus, Smolej, Lukas, Petrini, Mario, Offner, Fritz, Grosicki, Sebastian, Levin, Mark-David, Davis, Jaclyn, Banerjee, Hiya, Stefanelli, Tommaso, Hoever, Petra, Geisler, Christian
Publicado 2019

Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice

por Bouwer, Nathalie I., Jager, Agnes, Liesting, Crista, Kofflard, Marcel J.M., Brugts, Jasper J., Kitzen, Jos J.E.M., Boersma, Eric, Levin, Mark-David
Publicado 2020

Assessing the cost-effectiveness of a routine versus an extensive laboratory work-up in the diagnosis of anaemia in Dutch general practice

por Kip, Michelle MA, Schop, Annemarie, Stouten, Karlijn, Dekker, Soraya, Dinant, Geert-Jan, Koffijberg, Hendrik, Bindels, Patrick JE, IJzerman, Maarten J, Levin, Mark-David, Kusters, Ron
Publicado 2018

The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

por Kockerols, Camille C.B., Geelen, Inge, Levin, Mark-David, Janssen, Jeroen J.W.M., Dinmohamed, Avinash G., Hoogendoorn, Mels, Cornelissen, Jan J., Westerweel, Peter E.
Publicado 2022

2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab

por Bouwer, Nathalie I., Liesting, Crista, Kofflard, Marcel J. M., Brugts, Jasper J., Kock, Marc C. J., Kitzen, Jos J. E. M., Levin, Mark-David, Boersma, Eric
Publicado 2021